Cannamed is one of the few medical marijuana evaluation clinics in California that's owned and operated by a physician, which is mandatory per the California Medical Board. November 15, 2011
Cannamed, established in 2004, has made a name for itself in California by following the rules set forth by the California Medical Board...Multiple Sclerosis (MS) Clinic, and wrote “Multiple Sclerosis: New Hope and Practical Advice for Patients and their Families,” which is highly regarded within the MS community. In the book, he discuses the value of marijuana use in patients with MS.
Dr. Rosner is well-versed in the use of medical marijuana for pain management. He advises that medical marijuana should be recommended to patients by doctors who are knowledgeable in pain management. He also states that a thorough physical examination should be given, not a virtual conference online, before the recommendation is given. Doctors at medical marijuana clinics approve or recommend marijuana but do not prescribe it.
Conditions in which marijuana is valuable include chronic pain conditions such as: arthritis, fibromyalgia, cervical disc disease, lumbar disc disease, carpal tunnel syndrome, post-herpetic neuralgia, plantar fasciitis, menstrual cramps, migraine headaches, and peripheral neuropathy.
It can also be very effective in mood disorders, including: anxiety, panic attacks, bipolar disorder, depression, and post-traumatic stress disorder.
Other conditions that are responsive to marijuana include: insomnia, anorexia, asthma, glaucoma, acid reflux, irritable bowel syndrome, Crohn’s disease, chemotherapy side effects, nausea and vomiting, menopause, epilepsy, restless legs syndrome, and sleep apnea.
For more information about medical marijuana, or to book an appointment online, please visit Cannamed online at http://www.cannamed.com, or call toll-free at 866-624-1191. Cannamed is licensed and approved by the State of California Medical Board.
Professor Louis J. FNP# 41874
# # #
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2011/11/prweb8953379.htm